- Home
- QGEN vs TECH Comparison
QGEN vs TECH Comparison
Compare QGEN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- TECH
- Stock Information
- Founded
- QGEN 1986
- TECH 1976
- Country
- QGEN Netherlands
- TECH United States
- Employees
- QGEN N/A
- TECH N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QGEN Health Care
- TECH Health Care
- Exchange
- QGEN Nasdaq
- TECH Nasdaq
- Market Cap
- QGEN 9.1B
- TECH 7.8B
- IPO Year
- QGEN 1996
- TECH 1989
- Fundamental
- Price
- QGEN $48.36
- TECH $52.02
- Analyst Decision
- QGEN Buy
- TECH Buy
- Analyst Count
- QGEN 8
- TECH 12
- Target Price
- QGEN $50.68
- TECH $70.00
- AVG Volume (30 Days)
- QGEN 1.4M
- TECH 1.8M
- Earning Date
- QGEN 08-05-2025
- TECH 08-06-2025
- Dividend Yield
- QGEN 3.13%
- TECH 0.62%
- EPS Growth
- QGEN N/A
- TECH N/A
- EPS
- QGEN 0.42
- TECH 0.83
- Revenue
- QGEN $2,002,874,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- QGEN $6.36
- TECH $7.07
- Revenue Next Year
- QGEN $5.70
- TECH $5.72
- P/E Ratio
- QGEN $114.72
- TECH $62.63
- Revenue Growth
- QGEN 3.31
- TECH 4.72
- 52 Week Low
- QGEN $37.63
- TECH $46.01
- 52 Week High
- QGEN $48.90
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- QGEN 60.00
- TECH 50.81
- Support Level
- QGEN $47.38
- TECH $50.72
- Resistance Level
- QGEN $48.47
- TECH $55.53
- Average True Range (ATR)
- QGEN 0.79
- TECH 1.90
- MACD
- QGEN -0.13
- TECH -0.11
- Stochastic Oscillator
- QGEN 66.97
- TECH 37.77
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.